City and state officials gathered at 30th and Chestnut streets Tuesday for the groundbreaking of one of Philadelphia’s largest life science centers to date.
The company at the center of the project, Spark Therapeutics, is a history maker for the region, too: It was acquired by Roche for $4.8 billion in 2019, Philly’s largest-ever VC backed exit. At the time, the acquisition was a signal that the growing life sciences industry in Philadelphia was to be taken very, very seriously.
Now, Spark’s 500,000 square foot, six-story cell and gene therapy center will serve as the Philadelphia-based global center for Roche, and is one of many projects to bring more lab space to the region.
READ FULL ARTICLE HERE
